Rituximab

Results: 190



#Item
41Oncogene, 6184–6193  & 2007 Nature Publishing Group All rights reserved $30.00 www.nature.com/onc  ORIGINAL ARTICLE

Oncogene, 6184–6193 & 2007 Nature Publishing Group All rights reserved $30.00 www.nature.com/onc ORIGINAL ARTICLE

Add to Reading List

Source URL: www.nature.com

Language: English - Date: 2007-09-13 04:56:44
42Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID, 5 pages http://dx.doi.orgCase Report

Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID, 5 pages http://dx.doi.orgCase Report

Add to Reading List

Source URL: downloads.hindawi.com

Language: English - Date: 2015-03-24 09:53:49
43Clinical Commissioning Policy: The use of Rituximab as a second line agent for the eradication of inhibitors in patients with Acquired Haemophilia Reference: NHS England xxx/x/x 1

Clinical Commissioning Policy: The use of Rituximab as a second line agent for the eradication of inhibitors in patients with Acquired Haemophilia Reference: NHS England xxx/x/x 1

Add to Reading List

Source URL: www.engage.england.nhs.uk

Language: English - Date: 2015-03-23 14:07:33
44Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

Add to Reading List

Source URL: mesoblast.com

Language: English - Date: 2014-02-21 12:10:36
45TAG Mail 1st April 2015 TAG MEETINGS Nil TAG ACTIVITIES - Email discussions -- DTC approval of use of rituximab or adalimumab for sight-threatening uveitis

TAG Mail 1st April 2015 TAG MEETINGS Nil TAG ACTIVITIES - Email discussions -- DTC approval of use of rituximab or adalimumab for sight-threatening uveitis

Add to Reading List

Source URL: www.ciap.health.nsw.gov.au

Language: English - Date: 2015-04-01 21:15:12
46Clinical Commissioning Policy: Rituximab for the treatment of relapsing steroid sensitive nephrotic syndrome Reference: NHS ENGLAND XXX/X/X 1

Clinical Commissioning Policy: Rituximab for the treatment of relapsing steroid sensitive nephrotic syndrome Reference: NHS ENGLAND XXX/X/X 1

Add to Reading List

Source URL: www.engage.england.nhs.uk

Language: English - Date: 2015-03-23 16:03:50
47[removed]efc-schedule.pdf

[removed]efc-schedule.pdf

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2014-11-30 17:37:34
48Minutes of the SMC Meeting

Minutes of the SMC Meeting

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Language: English
49SMC  briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of

SMC briefing note Scottish Medicines Consortium advice to NHSScotland Monthly briefings are produced in order to help members of

Add to Reading List

Source URL: www.scottishmedicines.org.uk

Language: English
50ALLG Safety and Data Monitoring Committee

ALLG Safety and Data Monitoring Committee

Add to Reading List

Source URL: www.allg.org.au

Language: English - Date: 2014-05-29 08:24:27